J&J's experimental psoriasis drug shows promise against Bristol's treatment

Group 1 - Johnson & Johnson's experimental psoriasis drug demonstrated superior skin clearance compared to Bristol Myers Squibb's Sotyktu in two late-stage head-to-head trials [1]